Paul A. Hubbard

584 citations
14 papers · 474 indexed · h-index 11
Topics
Enzyme Structure and Function (5 papers)Biochemical and Molecular Research (4 papers)Porphyrin Metabolism and Disorders (2 papers)

In The Last Decade

Paul A. Hubbard

14 papers receiving 468 citations

Peers

Paul A. Hubbard
Comparison fields: 5 of 84
  • Molecular Biology 279
  • Pharmacology 91
  • Materials Chemistry 56
  • Oncology 53
  • Rheumatology 39
Replace Atsuko Miyajima with:
Atsuko Miyajima Japan
R. R. Martel United States
C. David Jones United States
Fabienne Z. Gaugaz Sweden
Philip N. Edwards United Kingdom
Wenhai Zhang China
Matthew E. Albertolle United States
Joscha Kotthaus Germany
Kevin N. Dack United Kingdom
Malkhey Verma India
Paul A. Hubbard relative to Atsuko Miyajima Japan Atsuko Miyajima's profile →
Citations per field
00.5×2.8×
Atsuko Miyajima · 1×
Citations per year

Countries citing papers authored by Paul A. Hubbard

Since Specialization
Citations

This map shows the geographic impact of Paul A. Hubbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Hubbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Hubbard more than expected).

Fields of papers citing papers by Paul A. Hubbard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Hubbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Hubbard. The network helps show where Paul A. Hubbard may publish in the future.

Co-authorship network of co-authors of Paul A. Hubbard

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Hubbard. A scholar is included among the top collaborators of Paul A. Hubbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Hubbard. Paul A. Hubbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 5
2 3
3 31
4 9
5 22
6 39
7 18
8 12
9 26
10 13
11 38
12 19
13 55
14 184

About Paul A. Hubbard

Paul A. Hubbard is a scholar working on Clinical Biochemistry, Toxicology and Pharmacology, having authored 14 papers that have together received 474 indexed citations. Recurring topics across this work include Enzyme Structure and Function (5 papers), Biochemical and Molecular Research (4 papers) and Porphyrin Metabolism and Disorders (2 papers). The work is most often cited by research in Pharmacology (91 citations), Transplantation (23 citations) and Biochemistry (39 citations). Paul A. Hubbard has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Jung‐Ja P. Kim, Anna L. Shen, Rosemary Paschke, Charles B. Kasper, Horst Schulz, Ramachandran Murali, Xiquan Liang, Ruma Banerjee, Catherine L. Drennan and Dominique Padovani. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026